Shaoyao Sujing tablet for Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006194

Enrollment

Unknown

Registered

2015-03-17

Start date

2015-03-22

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

high dose Shaoyao Sujing tablet group:Shaoyao Sujing tablet 4 tablets tid po

low dose Shaoyao Sujing tablet group:2 pices of Shaoyao Sujing tablets and 2 placebos tid po

placebo group:4 pices of placebos tid po

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for knee osteoarthriti; 2. aged from 40-70; 3. the Kellgren-Lawrence grading system shown Grade 0 to 3; 4. volunteered for the researchers.

Exclusion criteria

Exclusion criteria: 1. Kellgren-Lawrence grading system shown Grade 4; 2. Non-degenerative osteoarthritis, such as rheumatoid arthritis, gouty arthritis, infectious arthritis, Charcot arthritis, etc; 3. medication history for KOA within one week, such as NSAIDs, steroid, glucosamine, chondroitin sulfate, sodium hyaluronate,etc; 4. study drug allergy; 5. Serious medical illness.

Design outcomes

Primary

Measure	Time frame
WOMAC scores;	—

Secondary

Measure	Time frame
VAS;TCM syndrome score;	—

Countries

China

Contacts

Public ContactDingkun Lin

lindingkun@126.com+86 020 81887233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026